Researchers sought to explore the potential molecular basis for the association between SARS-CoV-2 and the development of Parkinsonism.
All articles by Virginia Schad
Researchers sought to examine whether prior influenza or other infections are associated with Parkinson disease more than 10 years after infection.
Researchers examined whether treatment with CD20 inhibitors resulted in worse COVID-19 outcomes among patients with immune-mediated diseases.
Researchers analyzed the temporal trend in racial and ethnic differences in the use of intravenous thrombolysis after stroke between 2009 and 2018 in a representative sample of adults in the US.
Researchers assessed the humoral and cell-mediated immune responses to SARS-CoV-2 mRNA-based vaccines in patients with a history of receiving CD20-targeted B-cell-depleting therapy.
Authors of a commentary assessed the role of IL-1 receptor antagonism, specifically anakinra, in the treatment of patients with severe COVID-19.
The primary objective of the VACOLUP study was to assess the tolerance of COVID-19 vaccines, including risk for incident flares, in patients with systemic lupus erythematosus.
Researchers assessed the risk for hyperinflammation and respiratory failure among hospitalized patients with COVID-19 and a systemic rheumatic disease.
This case-series described the effect of the COVID-19 pandemic on the incidence of movement disorders in children and adults.
This case series described the different reports of CVST with thrombocytopenia following receipt of the Johnson & Johnson COVID-19 vaccine.
The immunogenicity and safety of SARS-CoV-2 mRNA vaccines in patients with chronic inflammatory conditions receiving immunosuppressive therapy were determined.
This review of current literature discusses emerging therapies directed at COPD endotypes and pathobiological processes that manifest as the disease.
Chronic obstructive pulmonary disease (COPD) continues to be a major cause of disability and is one of the leading causes of mortality worldwide. Here, we summarize COPD pathology, available treatment options and additional potential pathways and targets for new therapeutic development.
Neuropathological changes in patients with coronavirus disease 2019 are relatively mild, with neuroinflammatory changes in the brain stem most often found.
Researchers analyzed the association of asthma and its subgroups with osteoporosis in the Korean adult population, and determined the effects of asthma on osteoporosis based on condition of asthma management.
Antiplatelet therapy may delay progression of COPD, decrease the risk for acute exacerbations, improve quality of life, and even reduce all-cause mortality.
Several lung disease-related factors may help predict the risk for hip fracture in current and former smokers.
Early sleep fragmentation, estimated by actigraphy, was found to be associated with worse cognitive impairment shortly after critical illness.
Sleep-disordered breathing and fragmented sleep are associated with higher levels of fasting glucose and hemoglobin A1c in black adults.
Weight gain after smoking cessation partially attenuates the beneficial effect on cardiovascular morbidity.
Investigators report cardiac arrhythmias with or without apnea among patients with epilepsy are associated with increased mortality risk.
The risk for development of obstructive sleep apnea (OSA) and the severity of disease in patients with multiple sclerosis (MS) may be affected by the location of the lesions.